Tilray Extends Sandoz Canadian Cannabis Pharmaceutical Collaboration Globally 2

Tilray Extends Sandoz Canadian Cannabis Pharmaceutical Collaboration Globally



Tilray Extends Sandoz Canadian Cannabis Pharmaceutical Collaboration Globally – RICH TV LIVE – December 18, 2018 – Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ: TLRY), a global pioneer in the production, research, and distribution of medical cannabis, announced today that it entered into a global framework agreement (the “Framework Agreement”) to collaborate with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars and a part of Novartis group, to increase availability of high quality medical cannabis products across the world.

An evolution of an existing alliance between Tilray and Sandoz Canada, the Framework Agreement represents the intentions of the two companies to jointly operate in jurisdictions where cannabis is or will be approved for medical purposes.

Tilray, a global pioneer of medical cannabis, has products available in twelve countries and operations in Australia & New Zealand, Canada, Germany, Latin America, and Portugal. This agreement builds on Tilray’s pioneering track-record as a company committed to making pharmaceutical-grade medical cannabis products available to patients in-need. Tilray was the first licensed medical cannabis producer in North America to obtain current Good Manufacturing Practice (cGMP) certification in accordance with the European Medicines Agency’s (EMA) standards.

This agreement represents a major milestone in the movement to provide access to safe, GMP-certified medical cannabis to patients in need across the world. Tilray is a global company and we’re thrilled to build upon the success and momentum from our existing agreement with Sandoz Canada by taking our partnership global. Sandoz AG will be a valuable partner as we work together to improve access to the highest quality medical cannabis products in countries all over the world.

Brendan Kennedy, Tilray Chief Executive Officer
The Framework Agreement outlines the opportunity for the companies to agree to collaborate in different forms:

Sandoz AG may support the global commercialization of Tilray’s non-smokable/non-combustible medical cannabis products;
Tilray and Sandoz AG may co-brand certain non-smokable/non-combustible products;
Tilray may supply non-smokable/ non-combustible medical cannabis products and license rights to and from Sandoz AG in relation to such products; Both companies may also partner to leverage best-in-class knowledge to educate pharmacists and physicians about medical cannabis products;
Tilray and Sandoz AG may collaborate to develop new innovative medical cannabis products.
About Tilray®

Tilray is a global pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids currently serving tens of thousands of patients in twelve countries spanning five continents.

Subscribe – https://www.youtube.com/c/RICHTVLIVE
Visit – http://www.richtvlive.com/ a one-stop shop for cryptocurrency, stocks, sports, travel and trending topics. #richtvlive #tilray #education
Join the RICH TV LIVE FREE Social Media Community – Download the Amino app on your phone or computer and follow the link – https://aminoapps.com/c/RICHTVLIVE/home/
Join the Conversation get the RICH TV LIVE app at Google Play – https://play.google.com/store/apps/details?id=com.app.richtvlive
iPhone App Store – https://itunes.apple.com/us/app/richtvlive/id1212158240?Is=1&mt=8

Popular Uploads – https://goo.gl/tbvXGg
Most Recent Upload – https://goo.gl/unKXBy
YouTube Channel Page – https://goo.gl/yUdG7w
Subscribe – https://goo.gl/q2tLnn
Rich TV Live Playlist – https://goo.gl/e116JF
YouTube support Tubebuddy – https://www.tubebuddy.com/RICHTVLIVE

Disclaimer

RICH TV LIVE company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RICH TV LIVE reports company profiles or other investor relations materials and presentations are subject to change. RICH TV LIVE and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.

Investing is inherently risky. RICH TV LIVE is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. Disclosure – https://www.richtvlive.com/feature-.html

We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission (“SEC”) at www.sec.gov/Canadian CSA https://www.securities-administrators.ca/.

source

Leave a Comment

Your email address will not be published. Required fields are marked *

×

Hello!

Click one of our representatives below to chat on WhatsApp or send us an email to [email protected]

 

× Order Via Whatsapp?